跳至主要内容
临床试验/NCT00184756
NCT00184756已完成3 期

Effect of Two Years Treatment With Growth Hormone on Height in SGA Children.

Novo Nordisk A/S38 个研究点 分布在 8 个国家目标入组 151 人开始时间: 2002年11月1日最近更新:
适应症
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
151
试验地点
38
主要终点
Evaluate effect on Height in SGA Children Treated with Growth Hormone

研究概览

简要总结

This trial is conducted in Europe and Middle East. Growth hormone in SGA Children This trial compares a treated group of patients with an untreated group of patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
3 Years 至 7 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Born small for gestational age with length and/or weight at -2 SDS or below at time of birth, according to country specific references.
  • Severe growth failure with no catch up and with height at -2.5 SDS or below, according to country specific references, for chronological age at time of inclusion

排除标准

  • Growth Hormone Deficiency (GHD)
  • Treatment with any medical product which may interfere with GH effects
  • Growth retardation associated with infections, severe chronic diseases including chromosomal anomaly or nutritional disorders

结局指标

主要结局

Evaluate effect on Height in SGA Children Treated with Growth Hormone

时间窗: After 2 years of treatment

次要结局

  • Appetite
  • Height SDS, yearly

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (38)

Loading locations...

相似试验

Efficacy on Height in SGA Children Treated With... | 临床试验